Among them, inflammatory markers, especially C-reactive protein (CRP), have been suggested to predict survival in different cancers (McMillan, 2008; Koch et al, 2009), including NSCLC (Kato et al, 2000; Forrest et al, 2003, 2004). The gene discussed is CRP; the disease is cancer.